By elucidating the role of TGM2 in promoting tumor development, shaping the immunosuppressive TME, and exploring its interactions with upstream transcription factors (TFs), this work aims to provide innovative strategies and therapeutic targets for precision targeted therapy, combination immunotherapy, and prognostic evaluation in lung cancer. This evidence concerns the gene TGM2 and neoplasm.